Antiviral strategies against influenza virus: towards new therapeutic approaches

Loregian, Arianna, Mercorelli, Beatrice, Nannetti, Giulio ORCID: https://orcid.org/0000-0003-3227-1537, Compagnin, Chiara and Palù, Giorgio 2014. Antiviral strategies against influenza virus: towards new therapeutic approaches. Cellular and Molecular Life Sciences 71 (19) , pp. 3659-3683. 10.1007/s00018-014-1615-2

Preview

PDF - Accepted Post-Print Version Download (413kB) | Preview

Abstract

Influenza viruses are major human pathogens responsible for respiratory diseases affecting millions of people worldwide and characterized by high morbidity and significant mortality. Influenza infections can be controlled by vaccination and antiviral drugs. However, vaccines need annual updating and give limited protection. Only two classes of drugs are currently approved for the treatment of influenza: M2 ion channel blockers and neuraminidase inhibitors. However, they are often associated with limited efficacy and adverse side effects. In addition, the currently available drugs suffer from rapid and extensive emergence of drug resistance. All this highlights the urgent need for developing new antiviral strategies with novel mechanisms of action and with reduced drug resistance potential. Several new classes of antiviral agents targeting viral replication mechanisms or cellular proteins/processes are under development. This review gives an overview of novel strategies targeting the virus and/or the host cell for counteracting influenza virus infection.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Pharmacy
Publisher:	Springer Verlag (Germany)
ISSN:	1420-682X
Date of First Compliant Deposit:	29 October 2018
Date of Acceptance:	18 March 2014
Last Modified:	04 Dec 2024 08:45
URI:	https://orca.cardiff.ac.uk/id/eprint/116278

Citation Data

Cited 133 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item